LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.
Cancer Lett
; 486: 58-70, 2020 08 28.
Article
in En
| MEDLINE
| ID: mdl-32439420
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Hormones
/
Carrier Proteins
/
Proto-Oncogene Proteins c-akt
/
RNA, Long Noncoding
/
ErbB Receptors
/
Erlotinib Hydrochloride
/
Lung Neoplasms
/
Membrane Proteins
/
Mutation
Type of study:
Prognostic_studies
Limits:
Adult
/
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Lett
Year:
2020
Document type:
Article
Affiliation country:
Country of publication: